The Insulin Paradox: How GLP-1 Drugs Reduce Belly Fat and Heart Risk

from VAT Trap · host Dr Edward Leatham

GLP-1 drugs seem paradoxical: they enhance insulin action yet shrink dangerous belly fat. The explanation lies in restoring normal insulin timing, reducing chronic insulin exposure, and reversing fat “spillover” from liver to abdomen. Real patient cases show rapid visceral fat loss alongside smoother glucose profiles and lower cardiovascular risk.See blog for more detailsAll VAT TRAP Podcasts

Episode metadata supplied by the publisher feed · Published Dec 14, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

The Insulin Paradox: How GLP-1 Drugs Reduce Belly Fat and Heart Risk

0:00 15:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

How to End Heart Disease with Dr. Fuhrman

Feb 11, 2026 ·45m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of VAT Trap?

This episode is 15 minutes long.

When was this VAT Trap episode published?

This episode was published on December 14, 2025.

Can I download this VAT Trap episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!